STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors

Akihiko Yoshida, Koji Tsuta, Makoto Ohno, Masayuki Yoshida, Yoshitaka Narita, Akira Kawai, Hisao Asamura, Ryoji Kushima

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Solitary fibrous tumor (SFT) is an uncommon fibroblastic neoplasm. Although histologic characteristics and frequent CD34 expression allow for an accurate diagnosis in the majority of SFT cases, a wide histologic spectrum and an occasional unexpected immunophenotype may pose diagnostic challenges. Molecular analyses have discovered that almost all SFTs harbor an NAB2-STAT6 fusion gene, which is considered specific to this tumor type. Recent studies have suggested that STAT6 immunohistochemistry is a reliable surrogate for detection of the fusion gene. Our aim was to validate these findings by examining a large number of SFT cases and a broad array of 30 different types of non-SFT tumors. A total of 49 SFTs with a range of histologic characteristics and 159 benign or malignant tumors that can mimic SFTs were retrieved and stained for STAT6. All 49 SFTs (100%) showed STAT6 expression that was restricted in the nucleus, mostly in a diffuse and strong manner, irrespective of the tumor sites and histologic patterns. The staining was uniform in most cases but was heterogenous in about 20% of the cases in which zonal staining attenuation was observed, likely reflecting variability in fixation or tissue ischemia. In contrast, only 4 non-SFT tumors (2.5%) exhibited weak nuclear STAT6 expression, whereas the remaining 155 cases showed no staining or often weak reactivity in both the cytoplasm and the nucleus. Therefore, nuclear STAT6 immunoreactivity is a highly sensitive and specific marker of SFTs and can be helpful when diagnosis is inconclusive by conventional methods.

Original languageEnglish
Pages (from-to)552-559
Number of pages8
JournalAmerican Journal of Surgical Pathology
Volume38
Issue number4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Solitary Fibrous Tumors
Immunohistochemistry
Neoplasms
Gene Fusion
Staining and Labeling
Tissue Fixation
Cytoplasm
Ischemia

Keywords

  • Immunohistochemistry
  • Solitary fibrous tumor
  • STAT6

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Yoshida, A., Tsuta, K., Ohno, M., Yoshida, M., Narita, Y., Kawai, A., ... Kushima, R. (2014). STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. American Journal of Surgical Pathology, 38(4), 552-559. https://doi.org/10.1097/PAS.0000000000000137

STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. / Yoshida, Akihiko; Tsuta, Koji; Ohno, Makoto; Yoshida, Masayuki; Narita, Yoshitaka; Kawai, Akira; Asamura, Hisao; Kushima, Ryoji.

In: American Journal of Surgical Pathology, Vol. 38, No. 4, 2014, p. 552-559.

Research output: Contribution to journalArticle

Yoshida, A, Tsuta, K, Ohno, M, Yoshida, M, Narita, Y, Kawai, A, Asamura, H & Kushima, R 2014, 'STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors', American Journal of Surgical Pathology, vol. 38, no. 4, pp. 552-559. https://doi.org/10.1097/PAS.0000000000000137
Yoshida, Akihiko ; Tsuta, Koji ; Ohno, Makoto ; Yoshida, Masayuki ; Narita, Yoshitaka ; Kawai, Akira ; Asamura, Hisao ; Kushima, Ryoji. / STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. In: American Journal of Surgical Pathology. 2014 ; Vol. 38, No. 4. pp. 552-559.
@article{9a3e3389a10d4840bbd1e7a92d9ff6dd,
title = "STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors",
abstract = "Solitary fibrous tumor (SFT) is an uncommon fibroblastic neoplasm. Although histologic characteristics and frequent CD34 expression allow for an accurate diagnosis in the majority of SFT cases, a wide histologic spectrum and an occasional unexpected immunophenotype may pose diagnostic challenges. Molecular analyses have discovered that almost all SFTs harbor an NAB2-STAT6 fusion gene, which is considered specific to this tumor type. Recent studies have suggested that STAT6 immunohistochemistry is a reliable surrogate for detection of the fusion gene. Our aim was to validate these findings by examining a large number of SFT cases and a broad array of 30 different types of non-SFT tumors. A total of 49 SFTs with a range of histologic characteristics and 159 benign or malignant tumors that can mimic SFTs were retrieved and stained for STAT6. All 49 SFTs (100{\%}) showed STAT6 expression that was restricted in the nucleus, mostly in a diffuse and strong manner, irrespective of the tumor sites and histologic patterns. The staining was uniform in most cases but was heterogenous in about 20{\%} of the cases in which zonal staining attenuation was observed, likely reflecting variability in fixation or tissue ischemia. In contrast, only 4 non-SFT tumors (2.5{\%}) exhibited weak nuclear STAT6 expression, whereas the remaining 155 cases showed no staining or often weak reactivity in both the cytoplasm and the nucleus. Therefore, nuclear STAT6 immunoreactivity is a highly sensitive and specific marker of SFTs and can be helpful when diagnosis is inconclusive by conventional methods.",
keywords = "Immunohistochemistry, Solitary fibrous tumor, STAT6",
author = "Akihiko Yoshida and Koji Tsuta and Makoto Ohno and Masayuki Yoshida and Yoshitaka Narita and Akira Kawai and Hisao Asamura and Ryoji Kushima",
year = "2014",
doi = "10.1097/PAS.0000000000000137",
language = "English",
volume = "38",
pages = "552--559",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors

AU - Yoshida, Akihiko

AU - Tsuta, Koji

AU - Ohno, Makoto

AU - Yoshida, Masayuki

AU - Narita, Yoshitaka

AU - Kawai, Akira

AU - Asamura, Hisao

AU - Kushima, Ryoji

PY - 2014

Y1 - 2014

N2 - Solitary fibrous tumor (SFT) is an uncommon fibroblastic neoplasm. Although histologic characteristics and frequent CD34 expression allow for an accurate diagnosis in the majority of SFT cases, a wide histologic spectrum and an occasional unexpected immunophenotype may pose diagnostic challenges. Molecular analyses have discovered that almost all SFTs harbor an NAB2-STAT6 fusion gene, which is considered specific to this tumor type. Recent studies have suggested that STAT6 immunohistochemistry is a reliable surrogate for detection of the fusion gene. Our aim was to validate these findings by examining a large number of SFT cases and a broad array of 30 different types of non-SFT tumors. A total of 49 SFTs with a range of histologic characteristics and 159 benign or malignant tumors that can mimic SFTs were retrieved and stained for STAT6. All 49 SFTs (100%) showed STAT6 expression that was restricted in the nucleus, mostly in a diffuse and strong manner, irrespective of the tumor sites and histologic patterns. The staining was uniform in most cases but was heterogenous in about 20% of the cases in which zonal staining attenuation was observed, likely reflecting variability in fixation or tissue ischemia. In contrast, only 4 non-SFT tumors (2.5%) exhibited weak nuclear STAT6 expression, whereas the remaining 155 cases showed no staining or often weak reactivity in both the cytoplasm and the nucleus. Therefore, nuclear STAT6 immunoreactivity is a highly sensitive and specific marker of SFTs and can be helpful when diagnosis is inconclusive by conventional methods.

AB - Solitary fibrous tumor (SFT) is an uncommon fibroblastic neoplasm. Although histologic characteristics and frequent CD34 expression allow for an accurate diagnosis in the majority of SFT cases, a wide histologic spectrum and an occasional unexpected immunophenotype may pose diagnostic challenges. Molecular analyses have discovered that almost all SFTs harbor an NAB2-STAT6 fusion gene, which is considered specific to this tumor type. Recent studies have suggested that STAT6 immunohistochemistry is a reliable surrogate for detection of the fusion gene. Our aim was to validate these findings by examining a large number of SFT cases and a broad array of 30 different types of non-SFT tumors. A total of 49 SFTs with a range of histologic characteristics and 159 benign or malignant tumors that can mimic SFTs were retrieved and stained for STAT6. All 49 SFTs (100%) showed STAT6 expression that was restricted in the nucleus, mostly in a diffuse and strong manner, irrespective of the tumor sites and histologic patterns. The staining was uniform in most cases but was heterogenous in about 20% of the cases in which zonal staining attenuation was observed, likely reflecting variability in fixation or tissue ischemia. In contrast, only 4 non-SFT tumors (2.5%) exhibited weak nuclear STAT6 expression, whereas the remaining 155 cases showed no staining or often weak reactivity in both the cytoplasm and the nucleus. Therefore, nuclear STAT6 immunoreactivity is a highly sensitive and specific marker of SFTs and can be helpful when diagnosis is inconclusive by conventional methods.

KW - Immunohistochemistry

KW - Solitary fibrous tumor

KW - STAT6

UR - http://www.scopus.com/inward/record.url?scp=84896647327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896647327&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000137

DO - 10.1097/PAS.0000000000000137

M3 - Article

C2 - 24625420

AN - SCOPUS:84896647327

VL - 38

SP - 552

EP - 559

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 4

ER -